[1]张兵兵,孔海英,崔龙慷,等.紫黄膏穴位贴敷联合富血小板血浆治疗膝骨关节炎的临床研究[J].中国中医骨伤科杂志,2025,33(05):13-16+21.[doi:10.20085/j.cnki.issn1005-0205.250503]
 ZHANG Bingbing,KONG Haiying,CUI Longkang,et al.Clinical Study of Zihuang Plaster Combined with Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2025,33(05):13-16+21.[doi:10.20085/j.cnki.issn1005-0205.250503]
点击复制

紫黄膏穴位贴敷联合富血小板血浆治疗膝骨关节炎的临床研究()
分享到:

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第33卷
期数:
2025年05期
页码:
13-16+21
栏目:
临床研究
出版日期:
2025-05-05

文章信息/Info

Title:
Clinical Study of Zihuang Plaster Combined with Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis
文章编号:
1005-0205(2025)05-0013-04
作者:
张兵兵1孔海英2崔龙慷1沈高波1朱宇尘1吴连国1△
1浙江中医药大学附属第二医院(杭州,310005); 2浙江省医疗健康集团杭州医院
Author(s):
ZHANG Bingbing1KONG Haiying2CUI Longkang1SHEN Gaobo1ZHU Yuchen1WU Lianguo1△
1The Second Affiliated Hospital of Zhejiang Chinese Medical University,Hangzhou 310005,China. 2Zhejiang Medical and Health Group Hangzhou Hospital,Hangzhou 310022,China.
关键词:
膝骨关节炎 紫黄膏 穴位贴敷 富血小板血浆 气滞血瘀证
Keywords:
knee osteoarthritis Zihuang plaster acupoint application platelet-rich plasma Qi stagnation and blood stasis
分类号:
R684.3
DOI:
10.20085/j.cnki.issn1005-0205.250503
文献标志码:
A
摘要:
目的:观察紫黄膏穴位贴敷联合富血小板血浆治疗膝骨关节炎(气滞血瘀证)的临床疗效。方法:将2023年1月至2024年1月收集的膝骨关节炎(气滞血瘀证)患者60例,随机分为对照组和观察组各30例。对照组患者采用富血小板血浆关节腔注射治疗,观察组患者采用紫黄膏贴敷联合富血小板血浆关节腔注射治疗。治疗3周后,评价两组患者临床疗效及安全性,并比较两组治疗前后视觉模拟量表(VAS)评分、中医证候评分、西安大略和麦克马斯特大学骨关节炎指数(WOMAC)评分及血清炎症因子水平(血清IL-1β和TNF-α)。结果:观察组患者总有效率(96.67%)高于对照组(80.00%),差异有统计学意义(P<0.05)。治疗前,两组患者中医证候评分、VAS评分、WOMAC评分及血清炎症因子水平比较,差异无统计学意义(P>0.05); 治疗后,两组患者上述指标均较治疗前降低,且观察组低于对照组,差异均有统计学意义(P<0.05)。两组患者不良反应比较,差异无统计学意(P>0.05)。结论:紫黄膏穴位贴敷联合富血小板血浆治疗膝骨关节炎(气滞血瘀证)疗效显著,在改善中医证候评分、VAS评分、WOMAC评分及炎症因子水平方面优于单纯富血小板血浆关节腔注射治疗。
Abstract:
Objective:To observe the clinical efficacy of Zihuang plaster acupoint application combined with platelet-rich plasma in the treatment of knee osteoarthritis with Qi stagnation and blood stasis.Methods:A total of 60 knee osteoarthritis patients with Qi stagnation and blood stasis collected from January 2023 to January 2024 were selected and divided into control group and observation group,with 30 cases in each group.The control group was treated with platelet-rich plasma,and the observation group was treated with Zihuang plaster acupoint application combined with platelet-rich plasma.After 3 weeks of treatment,the clinical efficacy and safety of the two groups were evaluated,and the visual analogue scale(VAS)score,traditional Chinese medicine(TCM)syndrome score,Western Ontario and McMaster University osteoarthritis index(WOMAC)score,and serum inflammatory factor levels(serum IL-1β and TNF-α)were compared between the two groups before and after treatment.Results:The total effective rate of the observation group was 96.67%,significantly higher than 80.00% of the control group(P<0.05).Before treatment,there was no significant difference in TCM syndrome score,VAS score,WOMAC score,and serum inflammatory factor level between the two groups(P>0.05).After treatment,the above indexes in the two groups were lower than those before treatment,and the observation group was lower than that in the control group,and the difference was statistically significant(P<0.05).There was no significant difference in adverse reactions between the two groups(P>0.05).Conclusion:Zihuang plaster acupoint application combined with platelet-rich plasma in the treatment of knee osteoarthritis with Qi stagnation and blood stasis is more effective than that of platelet-rich plasma in improving TCM syndrome score,VAS score,WOMAC score and inflammatory factor levels.

参考文献/References:

[1] KATZ J N,ARANT K R,LOESER R F.Diagnosis and treatment of hip and kneeosteoarthritis:a review[J].JAMA,2021,325(6):568-578.
[2] 中华医学会物理医学与康复学分会,四川大学华西医院.中国膝骨关节炎康复治疗指南(2023版)[J].中国循证医学杂志,2024,24(1):1-14.
[3] 林中秋,孙炳慧,张宇.富血小板血浆治疗膝骨关节炎的研究进展[J].中国中医骨伤科杂志,2022,30(12):85-88.
[4] 陈兆军.适时运用中西医结合方法,提高膝骨关节炎的临床疗效——《膝骨关节炎中医诊疗指南(2020年版)》解读[J].中医正骨,2022,34(3):1-2.
[5] 胡晶,毛伟波,庄爱文,等.《理瀹骈文》穴位贴敷疗法特色探析[J].上海针灸杂志,2024,43(1):96-99.
[6] 中华医学会骨科学分会关节外科学组,中国医师协会骨科医师分会骨关节炎学组,国家老年疾病临床医学研究中心(湘雅医院),等.中国骨关节炎诊疗指南(2021年版)[J].中华骨科杂志,2021,41(18):1291-1314.
[7] 中国中医药研究促进会骨伤科分会.膝骨关节炎中医诊疗指南(2020年版)[J].中医正骨,2020,32(10):1-14.
[8] 国家食品药品监督管理局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:349-353.
[9] 张茜玥,李昀姝,赵杰瑞,等.中医药联合富血小板血浆治疗膝骨关节炎进展[J].中药材,2024,47(1):261-267.
[10] 夏同林,张明焕,刘雷,等.富血小板血浆联合补肾活络方治疗膝骨关节炎的临床观察[J].中国中医骨伤科杂志,2024,32(12):53-57.
[11] 唐永秀,陈明,唐忠银,等.针刀技术联合富血小板血浆技术治疗膝骨关节炎的作用机制及对修复功能的影响[J].针灸临床杂志,2022,38(6):30-34.
[12] 中华中医药学会.膝骨关节炎中西医结合诊疗指南(2023年版)[J].中医正骨,2023,35(6):1-10.
[13] 张健哲,杨永菊,张宇,等.膝骨关节炎中医辨证存在的问题与对策[J].中华中医药学刊,2023,41(12):137-141.
[14] 郑俊侨,张俏菊,吴欣颖,等.穴位给药作用评价及应用情况研究进展[J].中国中药杂志,2024,49(14):3706-3713.
[15] 何国文,高大伟,胡栢均,等.穴位贴敷疗法联合体外冲击波治疗肱骨外上髁炎30例[J].中国中医骨伤科杂志,2022,30(7):61-64.
[16] 杜文飞.自拟膝痹方穴位贴敷联合西药治疗膝骨关节炎的疗效观察及对血清炎症因子、生活质量的影响[J].中国中医药科技,2023,30(6):1112-1114.
[17] ABRAMOFF B,CALDERA F E.Osteoarthritis:pathology,diagnosis,and treatment options[J].Med Clin North Am,2020,104(2):293-311.
[18] 董勇勇,段广斌,茹嘉,等.膝关节骨性关节炎患者血清IL-1β、TNF-α表达及其与术后疼痛指标的关系[J].中国实用医刊,2022,49(18):54-57.
[19] 王世海,武晔.膝骨关节炎患者血清基因表达水平与病情程度的关系[J].中国中医骨伤科杂志,2022,30(8):32-35.
[20] 李正红,郑志田,梁生林.紫荆皮镇痛抗炎活性部位的筛选[J].药品评价,2023,20(4):402-407.
[21] 王柯,叶寒露.大黄素对膝骨关节炎大鼠软骨细胞铁死亡的影响及机制研究[J].天津医药,2023,51(10):1090-1097.
[22] 齐伟,刘建军,王凯,等.当归活性成分治疗骨关节炎的药理学机制研究进展[J].中国医院药学杂志,2024,44(14):1708-1714.
[23] 郭晓萱,雷雨颖,孙培阳,等.藏红花素对膝关节骨性关节炎大鼠的治疗作用及TXNIP/NLRP3信号通路的影响[J].中国老年学杂志,2024,44(13):3284-3288.
[24] 郑曲,张宇,杨永菊,等.牛膝及其活性成分治疗骨关节炎的研究现状[J].中国临床药理学杂志,2023,39(20):3032-3036.

备注/Memo

备注/Memo:
基金项目:浙江省“领雁”研发攻关计划项目(2024C03213)
浙江省中医药科技计划项目(2024ZL514)
通信作者 E-mail:mdwu8535@126.com
更新日期/Last Update: 2025-05-15